{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:28:43Z","timestamp":1794360523818,"version":"4.9.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118440","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:45:28Z","timestamp":1756377928000},"page":"118440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Plasma rich in growth factors as a treatment for ocular fundus diseases: Mapping current applications and future directions"],"prefix":"10.1016","volume":"191","author":[{"given":"Eduardo","family":"Anitua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraia","family":"Reparaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Alkhraisat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2025.118440_bib1","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.biopha.2025.118440_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.diabres.2016.01.016","article-title":"Metabolic syndrome and eye diseases","volume":"113","author":"Poh","year":"2016","journal-title":"Diabetes Res Clin. Pr."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuron.2012.10.002","article-title":"The neuronal organization of the retina","volume":"76","author":"Masland","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118440_bib4","author":"AK","year":"2020","journal-title":"Retin. Pigment epithelium Health Dis."},{"key":"10.1016\/j.biopha.2025.118440_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/510285","article-title":"Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering","volume":"2014","author":"Fernandez-Robredo","year":"2014","journal-title":"J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5301\/EJO.2010.5730","article-title":"Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy","volume":"21","author":"Monaco","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.exer.2015.03.021","article-title":"Conjunctival fibrosis following filtering glaucoma surgery","volume":"142","author":"Schlunck","year":"2016","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.biopha.2025.118440_bib8","article-title":"Comparison of corneal epitheliotrophic factors of undiluted autologous Platelet-Rich plasma and autologous serum eye drops for dry eye disease","author":"Jongkhajornpong","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.biopha.2025.118440_bib9","article-title":"Use of allogeneic platelet-rich plasma for the treatment of autoimmune ocular surface disorders: case series","volume":"3","author":"Mancini","year":"2023","journal-title":"Front Ophthalmol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/09537104.2012.684730","article-title":"The role of platelet-rich plasma in tissue regeneration","volume":"24","author":"Alsousou","year":"2013","journal-title":"Platelets"},{"issue":"17","key":"10.1016\/j.biopha.2025.118440_bib11","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.3390\/ijms241713043","article-title":"Advances in platelet rich Plasma-Derived extracellular vesicles for regenerative Medicine: a Systematic-Narrative review","volume":"24","author":"Anitua","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.biopha.2025.118440_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007627","article-title":"Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling","volume":"4","author":"Qureshi","year":"2009","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.2003.83.3.835","article-title":"Regulation of wound healing by growth factors and cytokines","volume":"83","author":"Werner","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118440_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1399130","article-title":"Immunoregulatory role of platelet derivatives in the macrophage-mediated immune response","volume":"15","author":"Anitua","year":"2024","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib16","first-page":"529","article-title":"Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants","volume":"14","author":"Anitua","year":"1999","journal-title":"Int J. Oral. Maxillofac. Implants"},{"issue":"16","key":"10.1016\/j.biopha.2025.118440_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/15353702231199466","article-title":"Connective tissue growth factor: role in trabecular meshwork remodeling and intraocular pressure lowering","volume":"248","author":"Hassan","year":"2023","journal-title":"Exp. Biol. Med (Maywood)"},{"issue":"8","key":"10.1016\/j.biopha.2025.118440_bib18","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1111\/aos.13371","article-title":"Serum from plasma rich in growth factors regenerates rabbit corneas by promoting cell proliferation, migration, differentiation, adhesion and limbal stemness","volume":"95","author":"Etxebarria","year":"2017","journal-title":"Acta Ophthalmol. (Copenh)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14712598.2021.1945030","article-title":"Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus","volume":"22","author":"Anitua","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2025.118440_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/rme-2022-0118","article-title":"Platelet-rich plasma: are the obtaining methods, classification and clinical outcome always connected?","volume":"17","author":"Anitua","year":"2022","journal-title":"Regen. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/09537104.2020.1832653","article-title":"Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative Medicine","volume":"32","author":"Magalon","year":"2021","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102716","article-title":"Platelet-derived bio-products: classification update, applications, concerns and new perspectives","volume":"59","author":"Acebes-Huerta","year":"2020","journal-title":"Transfus. Apher. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib23","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jbm.a.35244","article-title":"Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion","volume":"103","author":"Anitua","year":"2015","journal-title":"J. Biomed. Mater. Res A"},{"key":"10.1016\/j.biopha.2025.118440_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.aanat.2021.151853","article-title":"The inclusion of leukocytes into platelet rich plasma reduces scaffold stability and hinders extracellular matrix remodelling","volume":"240","author":"Anitua","year":"2022","journal-title":"Ann. Anat."},{"key":"10.1016\/j.biopha.2025.118440_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2013.12.005","article-title":"Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop","volume":"119","author":"Anitua","year":"2014","journal-title":"Exp. Eye Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib26","doi-asserted-by":"crossref","first-page":"NP9","DOI":"10.1177\/1120672118803515","article-title":"Treatment of chronic and extreme ocular hypotension following glaucoma surgery with intraocular platelet-rich plasma: a case report","volume":"29","author":"Abdalrahman","year":"2019","journal-title":"Eur. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7040094","article-title":"Stem cell surgery and growth factors in retinitis pigmentosa patients: pilot study after literature review","volume":"7","author":"Limoli","year":"2019","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.biopha.2025.118440_bib28","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s12325-019-01040-2","article-title":"Management of deep retinal capillary ischemia by electromagnetic stimulation and Platelet-Rich plasma: preliminary clinical results","volume":"36","author":"Ozmert","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2025.118440_bib29","first-page":"229","article-title":"Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors","volume":"12","author":"S\u00e1nchez-\u00c1vila","year":"2019","journal-title":"Int Med Case Rep. J."},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib30","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1007\/s12325-020-01308-y","article-title":"Management of retinitis pigmentosa via Platelet-Rich plasma or combination with electromagnetic stimulation: retrospective analysis of 1-Year results","volume":"37","author":"Arslan","year":"2020","journal-title":"Adv. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2025.118440_bib31","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2217\/rme-2020-0056","article-title":"Treatment of resistant chronic central serous chorioretinopathy via platelet-rich plasma with electromagnetic stimulation","volume":"15","author":"Arslan","year":"2020","journal-title":"Regen. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4103\/ijo.IJO_1357_19","article-title":"Comparison of platelet-rich plasma and inverted internal limiting membrane flap for the management of large macular holes: a pilot study","volume":"68","author":"Babu","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib33","article-title":"Human amniotic membrane patch and platelet-rich plasma to promote retinal hole repair in a recurrent retinal detachment","author":"Di Tizio","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib34","article-title":"Long-term results of autologous plasma as adjuvant to pars plana vitrectomy in the treatment of high myopic full-thickness macular holes","author":"Figueroa","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/1120672120903704","article-title":"Outcome of autologous platelet concentrate and gas tamponade compared to heavy silicone oil tamponade in persistent macular hole surgery","volume":"31","author":"Schaub","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/ICB.0000000000000762","article-title":"Combined internal limiting membrane (ILM) flap and autologous plasma concentrate (APC) to close a large traumatic macular hole in a pediatric patient","volume":"15","author":"Finn","year":"2021","journal-title":"Retin. cases Brief. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2025.118440_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/a-1409-9268","article-title":"Highly concentrated autologous Platelet-Rich plasma restores foveal anatomy in lamellar macular hole surgery","volume":"238","author":"Hagenau","year":"2021","journal-title":"Klin. Mon. Augenheilkd."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02351-4","article-title":"Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy","volume":"12","author":"Limoli","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"02","key":"10.1016\/j.biopha.2025.118440_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/rme-2020-0075","article-title":"Evaluation of the effect of subtenon autologous platelet-rich plasma injections on visual functions in patients with retinitis pigmentosa","volume":"16","author":"Sahli","year":"2021","journal-title":"Regen. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib40","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10792-020-01662-4","article-title":"Surgical treatment of macular holes with and without the use of autologous platelet-rich plasma","volume":"41","author":"Shpak","year":"2021","journal-title":"Int Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/ICB.0000000000000957","article-title":"Plasma rich in growth factors for persistent macular hole: a pilot study","author":"Arias","year":"2022","journal-title":"Retin Cases Brief. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib42","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00417-021-05486-5","article-title":"Improving morphological outcome in lamellar macular hole surgery by using highly concentrated autologous platelet-rich plasma","volume":"260","author":"Hagenau","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib43","article-title":"Plasma rich in growth factors as treatment for a full-thickness macular hole due to macular telangiectasia type 2","author":"Rangel","year":"2021","journal-title":"Arch. Soc. Esp. Oftalmol. (Engl. Ed. )"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/clinpract12010007","article-title":"Plasma rich in growth factors in macular hole surgery","volume":"12","author":"Sanchez-Avila","year":"2022","journal-title":"Clin. Pract."},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12052050","article-title":"The Short-Term results of autologous Platelet-Rich plasma as an adjuvant to Re-Intervention in the treatment of refractory Full-Thickness macular holes","volume":"12","author":"Buzzi","year":"2023","journal-title":"J. Clin. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib46","article-title":"Platelet-rich plasma and macular hole surgery: a clue to their mode of action and the influence of anti-platelet agents","volume":"33","author":"D'Alterio","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib47","article-title":"Unilateral macular hole in a patient with retinitis pigmentosa treated with cover flap technique with the use of platelet-rich plasma under air tamponade: case report","author":"Giudice G","year":"2023","journal-title":"Retin. cases Brief. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054589","article-title":"Long-Term results of adjunct autologous Platelet-Rich plasma in lamellar macular hole surgery showing lasting restoration of foveal anatomy","volume":"24","author":"Hagenau","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000530199","article-title":"Macula-Off retinal detachment with refractory macular hole previously closed with autologous Platelet-Rich plasma: a case report","volume":"14","author":"Parisi","year":"2023","journal-title":"Case Rep. Ophthalmol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib50","first-page":"292","article-title":"Plasma rich in growth factors membrane as a macular hole treatment in a vitrectomized patient due to rhegmatogenous retinal detachment","volume":"98","author":"Rangel Gualdron","year":"2023","journal-title":"Arch. De. la Soc. Esp. De. Oftalmol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118440_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12103604","article-title":"Plasma rich in growth factors as an adjuvant agent in Non-Penetrating deep sclerectomy","volume":"12","author":"Rodr\u00edguez-Calvo","year":"2023","journal-title":"J. Clin. Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib52","first-page":"48","article-title":"Single-Stage endovitreal surgery of retinal detachment complicated by macular hole involving the Short-Term perfluorocarbon tamponade","author":"Takhchidi","year":"2023","journal-title":"Bull. Russ. State Med. Univ."},{"key":"10.1016\/j.biopha.2025.118440_bib53","doi-asserted-by":"crossref","DOI":"10.24075\/brsmu.2023.055","article-title":"Foveal microsurgical reconstruction technique for macular hole","author":"Takhchidi","year":"2023","journal-title":"Bull. Russ. State Med Univ."},{"key":"10.1016\/j.biopha.2025.118440_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.58240\/1829006X-2023.19.2-154","article-title":"Macular hole recovery surgery using autologous platelet rich plasma","author":"Voskanyan","year":"2023","journal-title":"Bull. Stomatol. Maxillofac. Surg."},{"key":"10.1016\/j.biopha.2025.118440_bib55","doi-asserted-by":"crossref","unstructured":"Bertolani Y., Arnaiz-Camacho A., Fernandez-Engroba J., Garcia-Arumi J., Zapata M.A. Successful use of PRGF-endoret(R) and ILM peeling for full thickness macular hole in MacTel type 2: A case report and review of literature. Eur J Ophthalmol. 2024:11206721241301933.","DOI":"10.1177\/11206721241301933"},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/joco.joco_216_22","article-title":"Electrophysiological and visual parameter changes in retinitis pigmentosa patients undergoing autologous Platelet-Rich plasma therapy: a randomized control trial","volume":"35","author":"Khan","year":"2024","journal-title":"J. Curr. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib57","doi-asserted-by":"crossref","DOI":"10.1177\/11206721241234419","article-title":"Platelet rich plasma for primary macular hole: a case series","author":"Parisi","year":"2024","journal-title":"Eur. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10792-024-03253-z","article-title":"Plasma rich in growth factors (PRGF) technology as adjuvant to ab externo trabeculectomy","volume":"44","author":"Pereira","year":"2024","journal-title":"Int Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib59","article-title":"The no-retina-touch technique: vitrectomy and platelet-rich plasma in the treatment of lamellar macular hole. new insights into pathogenesis","author":"Ricardi","year":"2024","journal-title":"Eye (Lond. )"},{"issue":"6","key":"10.1016\/j.biopha.2025.118440_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100476","article-title":"Safety results for geographic atrophy associated with Age-Related macular degeneration using subretinal cord blood Platelet-Rich plasma","volume":"4","author":"Rizzo","year":"2024","journal-title":"Ophthalmol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10792-024-03305-4","article-title":"Evaluation of the efficacy of subtenon autologous platelet-rich plasma therapy in patients with retinitis pigmentosa and factors affecting response to the treatment","volume":"44","author":"Sahli","year":"2024","journal-title":"Int Ophthalmol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoint.2024.100045","article-title":"Intravitreal cord-blood platelet-rich plasma for dry-AMD: safety profile","volume":"1","author":"Savastano","year":"2024","journal-title":"AJO Int."},{"key":"10.1016\/j.biopha.2025.118440_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1344107","article-title":"Efficacy and safety of platelet-rich plasma for acute nonarteritic anterior ischemic optic neuropathy: a prospective cohort study","volume":"11","author":"Jin","year":"2024","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000544755","article-title":"Electromagnetic iontophoresis: a novel nonsurgical method for the treatment of dense vitreous and retinal hemorrhages","volume":"16","author":"Arslan","year":"2025","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib65","first-page":"1","article-title":"First case report of successful use of ILM peeling, inverted flap and PRGF-Endoret(R) in bilateral macular hole in behcet's disease","author":"Bertolani","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib66","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.16690","article-title":"Autologous platelet concentrate in epiretinal membrane surgery: a single-centre prospective comparative non-inferiority study","volume":"103","author":"Furashova","year":"2025","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10384-025-01166-7","article-title":"Long-term outcomes and prognosis in vitrectomy with autologous platelet concentrate injection for large, high myopic, or recurrent macular holes","volume":"69","author":"Hong","year":"2025","journal-title":"Jpn J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib68","doi-asserted-by":"crossref","DOI":"10.1097\/ICB.0000000000001765","article-title":"Membrane rich in growth factors for the treatment of refractory macular holes and its effects on retinal vasculature and anatomy","author":"Khouri","year":"2025","journal-title":"Retin Cases Brief. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2025.118440_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14093030","article-title":"In vivo optical coherence tomography outcomes of hypotony after trabeculectomy management with autologous blood injection: a Single-Center retrospective study","volume":"14","author":"Sacchi","year":"2025","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.118440_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100732","article-title":"Intravitreal injections of cord blood Platelet-Rich plasma in dry Age-Related macular degeneration: regenerative therapy","author":"Savastano","year":"2025","journal-title":"Ophthalmol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-025-04019-6","article-title":"Effect of autologous whole blood in surgery for full-thickness macular hole: a propensity score matching analysis","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Ophthalmol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118440_bib72","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","author":"DeLong","year":"2012","journal-title":"Arthroscopy"},{"issue":"20","key":"10.1016\/j.biopha.2025.118440_bib73","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2106\/JBJS.16.01374","article-title":"A call for standardization in Platelet-Rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature","volume":"99","author":"Chahla","year":"2017","journal-title":"J. Bone Jt. Surg. Am."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jcp.20391","article-title":"Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications","volume":"205","author":"Doucet","year":"2005","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.118440_bib75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajo.2015.10.026","article-title":"Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by optical coherence tomography angiography","volume":"162","author":"Nemiroff","year":"2016","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/13816810.2010.544361","article-title":"Why some photoreceptors die, while others remain dormant: lessons from RPE65 and LRAT associated retinal dystrophies","volume":"32","author":"Koenekoop","year":"2011","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.celrep.2016.03.022","article-title":"Two-Step reactivation of dormant cones in retinitis pigmentosa","volume":"15","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"issue":"33","key":"10.1016\/j.biopha.2025.118440_bib78","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.1073\/pnas.1706994114","article-title":"Elevated IOP alters the space-time profiles in the center and surround of both ON and OFF RGCs in mouse","volume":"114","author":"Sabharwal","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaophthalmol.2015.5490","article-title":"The survival of cone photoreceptors in retinitis pigmentosa","volume":"134","author":"Wong","year":"2016","journal-title":"JAMA Ophthalmol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118440_bib80","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00417-013-2314-7","article-title":"Functional rescue of cone photoreceptors in retinitis pigmentosa","volume":"251","author":"Sahel","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib81","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/17469899.2017.1259566","article-title":"Role of BDNF\/TrkB pathway in the visual system: therapeutic implications for glaucoma","volume":"12","author":"Mysona","year":"2017","journal-title":"Expert Rev. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-016-0312-5","article-title":"How electromagnetic fields can influence adult stem cells: positive and negative impacts","volume":"7","author":"Maziarz","year":"2016","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13287-020-1566-5","article-title":"Pulsed electromagnetic fields potentiate the paracrine function of mesenchymal stem cells for cartilage regeneration","volume":"11","author":"Parate","year":"2020","journal-title":"Stem Cell Res Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12432","article-title":"Extremely low-frequency electromagnetic fields accelerates wound healing modulating MMP-9 and inflammatory cytokines","volume":"51","author":"Patruno","year":"2018","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib85","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/jop.2007.0061","article-title":"Trans-scleral delivery of antiangiogenic proteins","volume":"24","author":"Demetriades","year":"2008","journal-title":"J. Ocul. Pharm. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2025.118440_bib86","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.drudis.2019.05.006","article-title":"Therapeutic implications of nanomedicine for ocular drug delivery","volume":"24","author":"Meng","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/17425247.2018.1406918","article-title":"Transscleral passive and iontophoretic transport: theory and analysis","volume":"15","author":"Li","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020455","article-title":"High-Frequency repetitive transcranial magnetic stimulation (rTMS) improves functional recovery by enhancing neurogenesis and activating BDNF\/TrkB signaling in ischemic rats","volume":"18","author":"Luo","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ICB.0000000000000709","article-title":"Retinal microvasculature alteration in paracentral acute middle maculopathy and acute macular neuroretinopathy: a quantitative optical coherence tomography angiography study","volume":"14","author":"Kulikov","year":"2020","journal-title":"Retin Cases Brief. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib90","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.jcjo.2017.11.020","article-title":"Simultaneous paracentral acute middle maculopathy and purtscher-like retinopathy after acute febrile illness","volume":"53","author":"Niyousha","year":"2018","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib91","article-title":"Study of vessel density by optical coherence tomography angiography in patients with central serous chorioretinopathy after low-\ufb02uence photodynamic therapy","volume":"30","author":"Cennamo","year":"2020","journal-title":"Photo Photo Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib92","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1167\/iovs.10-6287","article-title":"Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial","volume":"52","author":"Lois","year":"2011","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118440_bib93","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bjophthalmol-2011-301287","article-title":"A comparison of several methods of macular hole measurement using optical coherence tomography, and their value in predicting anatomical and visual outcomes","volume":"96","author":"Wakely","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118440_bib94","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/bjophthalmol-2015-307014","article-title":"Role of macular hole angle in macular hole closure","volume":"99","author":"Chhablani","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118440_bib95","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/IAE.0b013e318297a21a","article-title":"Novel surgical technique for closure of large full-thickness macular holes","volume":"33","author":"Wong","year":"2013","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/IAE.0000000000002013","article-title":"Macular hole hydrodissection: surgical technique for the treatment of persistent, chronic, and large macular holes","volume":"39","author":"Felfeli","year":"2019","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3928\/23258160-20121221-15","article-title":"Arcuate retinotomy for the repair of large macular holes","volume":"44","author":"Charles","year":"2013","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib98","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ICB.0000000000000513","article-title":"Anterior lens capsule in the management of chronic Full-Thickness macular hole","volume":"12","author":"Yepez","year":"2018","journal-title":"Retin Cases Brief. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2025.118440_bib99","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ophtha.2010.02.011","article-title":"Inverted internal limiting membrane flap technique for large macular holes","volume":"117","author":"Michalewska","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib100","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000002320","article-title":"A human amniotic membrane plug to promote retinal breaks repair and recurrent macular hole closure","volume":"39","author":"Rizzo","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.biopha.2025.118440_bib101","first-page":"229","article-title":"Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors","volume":"12","author":"Sanchez-Avila","year":"2019","journal-title":"Int Med Case Rep. J."},{"issue":"10","key":"10.1016\/j.biopha.2025.118440_bib102","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1167\/iovs.08-3057","article-title":"Effect of various platelet preparations on retinal muller cells","volume":"50","author":"Burmeister","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib103","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000477353","article-title":"A review of Platelet-Rich plasma: history, biology, mechanism of action, and classification","volume":"4","author":"Alves","year":"2018","journal-title":"Ski. Appendage Disord."},{"issue":"10","key":"10.1016\/j.biopha.2025.118440_bib104","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00417-022-05676-9","article-title":"M. Visual improvement and regeneration of retinal layers in eyes with small, medium, and large idiopathic full-thickness macular holes treated with the inverted internal limiting membrane flap technique over a period of 12 months","volume":"260","author":"Friedrich","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118440_bib105","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/IAE.0000000000002326","article-title":"Pars plana vitrectomy for the treatment of tractional and degenerative lamellar macular holes: functional and anatomical results","volume":"39","author":"Figueroa","year":"2019","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.biopha.2025.118440_bib106","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1007\/s00018-021-03796-9","article-title":"The complement system in age-related macular degeneration","volume":"78","author":"Armento","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.118440_bib107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin Eye Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118440_bib108","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2025.118440_bib109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","article-title":"Age-related macular degeneration: genetics and biology coming together","volume":"15","author":"Fritsche","year":"2014","journal-title":"Annu Rev. Genom. Hum. Genet"},{"issue":"10411","key":"10.1016\/j.biopha.2025.118440_bib110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2025.118440_bib111","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1159\/000517794","article-title":"The use of neuroprotective agents in treating geographic atrophy","volume":"64","author":"Scholl","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.biopha.2025.118440_bib112","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.150.6.2231","article-title":"Role of heavy chain constant domains in antibody-antigen interaction. Apparent specificity differences among streptococcal IgG antibodies expressing identical variable domains","volume":"150","author":"Cooper","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118440_bib113","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3389\/fimmu.2020.00942","article-title":"Cord blood platelet rich plasma derivatives for clinical applications in Non-transfusion Medicine","volume":"11","author":"Samarkanova","year":"2020","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib114","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1167\/iovs.15-17864","article-title":"Platelet-Derived growth factor preserves retinal synapses in a rat model of ocular hypertension","volume":"57","author":"Chong","year":"2016","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin Eye Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib116","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2025.118440_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.004","article-title":"Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases","volume":"58","author":"Jones","year":"2017","journal-title":"Prog. Retin Eye Res"},{"issue":"6","key":"10.1016\/j.biopha.2025.118440_bib118","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jcrs.2003.10.035","article-title":"Long-term results of deep sclerectomy with collagen implant","volume":"30","author":"Shaarawy","year":"2004","journal-title":"J. Cataract Refract Surg."},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib119","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1755-3768.2009.01630.x","article-title":"Factors associated with non-penetrating deep sclerectomy failure in controlling intraocular pressure","volume":"89","author":"Guedes","year":"2011","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118440_bib120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","article-title":"Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva","volume":"10","author":"Broadway","year":"2001","journal-title":"J. Glaucoma"},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib121","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5005\/jp-journals-10008-1160","article-title":"Wound healing modulation in glaucoma filtration Surgery- conventional practices and new perspectives: antivascular endothelial growth factor and novel agents (Part II)","volume":"8","author":"Fan Gaskin","year":"2014","journal-title":"J. Curr. Glaucoma Pr."},{"issue":"25","key":"10.1016\/j.biopha.2025.118440_bib122","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1056\/NEJMra1413352","article-title":"Ischemic optic neuropathies","volume":"372","author":"Biousse","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib124","unstructured":"Chawla H., Tripathy K., Vohra V. Retinal Dystrophies. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Koushik Tripathy declares no relevant financial relationships with ineligible companies. Disclosure: Vishal Vohra declares no relevant financial relationships with ineligible companies.: StatPearls Publishing. Copyright \u00a9 2025, StatPearls Publishing LLC.; 2025."},{"key":"10.1016\/j.biopha.2025.118440_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100907","article-title":"Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials","volume":"82","author":"Pfau","year":"2021","journal-title":"Prog. Retin Eye Res"},{"issue":"34","key":"10.1016\/j.biopha.2025.118440_bib126","first-page":"1607","article-title":"[Evaluation of the quality of life in ophthalmology]","volume":"31","author":"Br\u00e9mond-Gignac","year":"2002","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.biopha.2025.118440_bib127","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo-2024-325310","article-title":"Expert CONsensus on visual evaluation in retinal disease manaGEment: the CONVERGE study","volume":"109","author":"Anderson","year":"2025","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118440_bib128","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ophtha.2017.03.044","article-title":"Diagnostic accuracy of spectralis SD OCT automated macular layers segmentation to discriminate normal from early glaucomatous eyes","volume":"124","author":"Pazos","year":"2017","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.biopha.2025.118440_bib129","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamaophthalmol.2021.0146","article-title":"A global assessment of eye health and quality of life: a systematic review of systematic reviews","volume":"139","author":"Assi","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.biopha.2025.118440_bib130","series-title":"Platelet Rich Plasma in Orthopaedics and Sports Medicine","first-page":"29","article-title":"Characterization of plasma rich in growth factors (PRGF): components and formulations","author":"Anitua","year":"2018"},{"issue":"1","key":"10.1016\/j.biopha.2025.118440_bib131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13048-025-01667-6","article-title":"Platelet-rich plasma activation: are there differential effects in reproductive Medicine?","volume":"18","author":"Anitua","year":"2025","journal-title":"J. Ovarian Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225006341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T02:46:27Z","timestamp":1760582787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225006341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":131,"alternative-id":["S0753332225006341"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118440","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma rich in growth factors as a treatment for ocular fundus diseases: Mapping current applications and future directions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118440"}}